$24.74
At close: Jun 23 EDT
$24.74
0.000.00%
Pre-Market: 4:03 PM EDT
Comments
Loading...
Pacira BioSciences Stock Guidance | NASDAQ:PCRX | Benzinga
Pacira BioSciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/08/2025 | PCRX | Pacira BioSciences | FY | 2025 | — | — | — | $725.00M | $765.00M | $752.89M | Get Alert |
| 02/27/2025 | PCRX | Pacira BioSciences | FY | 2025 | — | — | — | $725.00M | $765.00M | $747.55M | Get Alert |
| 01/10/2025 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $701.00M | $701.00M | $695.18M | Get Alert |
| 11/06/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | — | Get Alert |
| 07/30/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | $694.66M | Get Alert |
| 05/07/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | $691.61M | Get Alert |
| 02/29/2024 | PCRX | Pacira BioSciences | FY | 2024 | — | — | — | $680.00M | $705.00M | $722.45M | Get Alert |
| 01/04/2024 | PCRX | Pacira BioSciences | Q4 | 2023 | — | — | — | $181.20M | $181.20M | $179.91M | Get Alert |
| 01/04/2024 | PCRX | Pacira BioSciences | FY | 2023 | — | — | — | $675.00M | $675.00M | $677.30M | Get Alert |
| 01/05/2023 | PCRX | Pacira BioSciences | FY | 2022 | $2.50 | — | $2.77 | $666.80M | $666.80M | $671.30M | Get Alert |
| 10/13/2022 | PCRX | Pacira BioSciences | Q3 | 2022 | — | — | — | $167.50M | $167.50M | $172.72M | Get Alert |
| 07/14/2022 | PCRX | Pacira BioSciences | Q2 | 2022 | — | — | — | $169.40M | $169.40M | $174.91M | Get Alert |
| 04/12/2022 | PCRX | Pacira BioSciences | Q1 | 2022 | — | — | — | $157.40M | $158.40M | $162.85M | Get Alert |
| 01/06/2022 | PCRX | Pacira BioSciences | FY | 2021 | — | — | — | $540.70M | $541.70M | $534.70M | Get Alert |
| 07/13/2021 | PCRX | Pacira BioSciences | Q2 | 2021 | — | — | — | $135.60M | $135.60M | $128.01M | Get Alert |
| 01/07/2021 | PCRX | Pacira BioSciences | FY | 2020 | — | — | — | $429.60M | $429.60M | $427.70M | Get Alert |
FAQ
What is the most recent guidance for Pacira BioSciences (PCRX)?
There have been no specific sales or earnings guidance reported for Pacira BioSciences in recent months.
Browse guidance and forecast on all stocks.
